Tumour suppressor activity of p53 has been suggested to rely on acetylation of its C terminus. Here Wang and colleagues show that the Rho GTPase-activating protein ArhGAP30 is required for P300-mediated p53 acetylation and functional activation in colorectal cancer, and identify ArhGAP30 as a potential prognostic marker.
- Jilin Wang
- Jin Qian
- Jing-Yuan Fang